Tuberculosis in house staff: A decision analysis comparing the tuberculin screening strategy with the BCG vaccination

P. D. Greenberg, K. G. Lax, C. B. Schechter

Research output: Contribution to journalArticlepeer-review

54 Scopus citations

Abstract

The BCG vaccination is not recommended for health-care workers in the United States. The current strategy against tuberculosis in tuberculin-negative house staff is an annual tuberculin screening test followed by chemoprophylaxis with isoniazid for a positive result. We performed a decision analysis that unequivocally concluded that the BCG vaccination leads to fewer cases of tuberculosis in this population over a 10-yr period. The BCG vaccine requires only an efficacy rate of at least 13.1% to prevent more cases of tuberculosis than the current strategy. This threshold value is independent of the annual tuberculin conversion rate. This study provides a framework, based on the best information in the literature, on which a well-informed decision regarding tuberculosis prevention can be made. Therefore, this analysis demonstrates that the BCG vaccine should be considered for tuberculin-negative house officers and medical students working in high risk areas of the United States.

Original languageEnglish (US)
Pages (from-to)490-495
Number of pages6
JournalAmerican Review of Respiratory Disease
Volume143
Issue number3 I
DOIs
StatePublished - Jan 1 1991
Externally publishedYes

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint

Dive into the research topics of 'Tuberculosis in house staff: A decision analysis comparing the tuberculin screening strategy with the BCG vaccination'. Together they form a unique fingerprint.

Cite this